FDA
approval
· 2018-08-17
FDA Approved: SODIUM NITROPRUSSIDE — Original Application (Somerset Therapeutics, LLC)
Summary
FDA approved the original ANDA for Sodium nitroprusside from Somerset Therapeutics, LLC, authorizing a generic IV vasodilator for use in hypertensive emergencie…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SODIUM NITROPRUSSIDE (SODIUM NITROPRUSSIDE)